4//SEC Filing
Parikh Asit 4
Accession 0001209191-23-033017
CIK 0001783183other
Filed
May 29, 8:00 PM ET
Accepted
May 30, 6:55 PM ET
Size
7.8 KB
Accession
0001209191-23-033017
Insider Transaction Report
Form 4
Parikh Asit
Director
Transactions
- Award
Common Stock
2023-05-25+9,000→ 32,500 total - Award
Stock Option (Right to Buy)
2023-05-25+15,000→ 15,000 totalExercise: $11.72Exp: 2033-05-24→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]The Restricted Stock Units ("RSUs") were granted on May 25, 2023, pursuant to the Issuer's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing service on the Board through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
- [F2]The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest and/or become exercisable on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing in service on the Board through such vesting date.
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0001796787
Filing Metadata
- Form type
- 4
- Filed
- May 29, 8:00 PM ET
- Accepted
- May 30, 6:55 PM ET
- Size
- 7.8 KB